Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-15 Baroldi Joseph EVP, Chief Business Officer Option exercise · Restricted Stock Unit −10,837 66,511
2025-03-11 Monia Brett P Chief Executive Officer Sale 10b5-1 −140 $32.32 $5K 180,980
2025-02-28 Swayze Eric EVP Research Other acquisition +415 $28.21 $12K 48,432
2025-02-28 O'NEIL PATRICK R. EVP CLO & General Counsel Other acquisition +554 $28.21 $16K 56,799
2025-02-28 Monia Brett P Chief Executive Officer Other acquisition +437 $28.21 $12K 181,120
2025-02-28 Geary Richard S EVP, Chief Development Officer Other acquisition +415 $28.21 $12K 99,492
2025-02-28 Birchler Brian EVP, Corp and Development Ops Other acquisition +414 $28.21 $12K 55,465
2025-02-28 BENNETT C FRANK EVP, Chief Scientific Officer Other acquisition +320 $28.21 $9K 93,466
2025-02-20 O'NEIL PATRICK R. EVP CLO & General Counsel Sale 10b5-1 −1,207 $32.35 $39K 56,245
2025-02-04 O'NEIL PATRICK R. EVP CLO & General Counsel Sale 10b5-1 −6,165 $31.62 $195K 57,452
2025-02-04 Monia Brett P Chief Executive Officer Sale 10b5-1 −38,843 $31.65 $1.2M 180,683
2025-01-31 Swayze Eric EVP Research Sale −1,367 $32.31 $44K 48,017
2025-01-31 Schneider Eugene EVP, Chf Clinical Develop Ofcr Sale −1,484 $32.20 $48K 61,056
2025-01-31 O'NEIL PATRICK R. EVP CLO & General Counsel Sale −1,406 $32.49 $46K 63,617
2025-01-31 Monia Brett P Chief Executive Officer Sale −13,242 $32.45 $430K 219,526
2025-01-31 HOUGEN ELIZABETH L EVP, Finance & CFO Sale −1,523 $32.44 $49K 110,500
2025-01-31 Geary Richard S EVP, Chief Development Officer Sale −1,406 $32.40 $46K 99,077
2025-01-31 BENNETT C FRANK EVP, Chief Scientific Officer Sale −1,327 $32.46 $43K 93,146
2025-01-30 Swayze Eric EVP Research Grant or award +3,714 49,384
2025-01-30 Schneider Eugene EVP, Chf Clinical Develop Ofcr Grant or award +4,032 62,540

Page 31 of 34 · 668 trades